AU Stock MarketDetailed Quotes

Chimeric Therapeutics Ltd (CHM)

Watchlist

0.165
-0.035-17.50%

20min DelayMarket Closed May 1 16:00 AET

7.29MMarket Cap-0.21P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chimeric Therapeutics Ltd (CHM) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2025

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

Total revenue

3.97M

Operating revenue

--3.97M

----

Cost of revenue

846.76K

Gross profit

3.12M

Operating expense

-13.26%18.23M

-28.72%21.02M

71.54%29.49M

9.55%17.19M

15.69M

Selling and administrative expenses

-22.96%7.05M

-23.24%9.15M

30.50%11.92M

48.14%9.14M

--6.17M

-Selling and marketing expense

----

--212.76K

----

--148.69K

-General and administrative expense

-21.13%7.05M

-25.02%8.94M

30.50%11.92M

51.80%9.14M

--6.02M

Research and development costs

6.22%9.76M

-31.80%9.19M

160.43%13.47M

36.94%5.17M

--3.78M

Depreciation amortization depletion

2.58%1.03M

4.22%1.01M

1.64%965.35K

12.14%949.76K

--846.96K

-Depreciation and amortization

2.58%1.03M

4.22%1.01M

1.64%965.35K

12.14%949.76K

--846.96K

Other operating expenses

-76.80%387.43K

-46.52%1.67M

61.95%3.12M

-60.63%1.93M

--4.9M

Operating profit

28.11%-15.11M

28.72%-21.02M

-71.54%-29.49M

-9.55%-17.19M

-15.69M

Net non-operating interest income (expenses)

22.55%-163.02K

71.79%-210.5K

-19.00%-746.28K

-19,310.40%-627.15K

-3.23K

Non-operating interest income

-60.43%48.01K

340.11%121.32K

112.41%27.57K

390.44%12.98K

--2.65K

Non-operating interest expense

-36.40%211.03K

-57.12%331.81K

20.89%773.85K

10,792.07%640.13K

--5.88K

Other net income (expenses)

-43.11%4.95M

80.49%8.71M

131.77%4.83M

889.33%2.08M

-263.79K

Special income (charges)

70.62%-292

59.40%-994

-18.55%-2.45K

---2.07K

----

-Gain on sale of property,plant,equipment

70.62%-292

59.40%-994

-18.55%-2.45K

---2.07K

----

Other non-operating income (expenses)

-43.12%4.96M

80.42%8.71M

131.66%4.83M

890.11%2.08M

---263.79K

Income before tax

17.58%-10.32M

50.72%-12.52M

-75.71%-25.41M

4.33%-14.46M

-15.11M

Income tax

1,045.08%110.81K

-89.57%9.68K

-43.31%92.82K

163.72K

Earnings from equity interest net of tax

Net income

16.76%-10.43M

50.86%-12.53M

-74.38%-25.5M

3.24%-14.62M

-15.11M

Net income continuous operations

16.76%-10.43M

50.86%-12.53M

-74.38%-25.5M

3.24%-14.62M

---15.11M

Noncontrolling interests

Net income attributable to the company

16.76%-10.43M

50.86%-12.53M

-74.38%-25.5M

3.24%-14.62M

-15.11M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

16.76%-10.43M

50.86%-12.53M

-74.38%-25.5M

3.24%-14.62M

-15.11M

Diluted earnings per share

55.08%-0.77

69.44%-1.7143

-45.07%-5.6095

47.35%-3.8667

-7.3437

Basic earnings per share

55.08%-0.77

69.44%-1.7143

-45.07%-5.6095

47.35%-3.8667

-7.3437

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2025	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021
Total revenue	3.97M
Operating revenue	--3.97M	----	----	----	----
Cost of revenue	846.76K
Gross profit	3.12M
Operating expense	-13.26%18.23M	-28.72%21.02M	71.54%29.49M	9.55%17.19M	15.69M
Selling and administrative expenses	-22.96%7.05M	-23.24%9.15M	30.50%11.92M	48.14%9.14M	--6.17M
-Selling and marketing expense	----	--212.76K	----	----	--148.69K
-General and administrative expense	-21.13%7.05M	-25.02%8.94M	30.50%11.92M	51.80%9.14M	--6.02M
Research and development costs	6.22%9.76M	-31.80%9.19M	160.43%13.47M	36.94%5.17M	--3.78M
Depreciation amortization depletion	2.58%1.03M	4.22%1.01M	1.64%965.35K	12.14%949.76K	--846.96K
-Depreciation and amortization	2.58%1.03M	4.22%1.01M	1.64%965.35K	12.14%949.76K	--846.96K
Other operating expenses	-76.80%387.43K	-46.52%1.67M	61.95%3.12M	-60.63%1.93M	--4.9M
Operating profit	28.11%-15.11M	28.72%-21.02M	-71.54%-29.49M	-9.55%-17.19M	-15.69M
Net non-operating interest income (expenses)	22.55%-163.02K	71.79%-210.5K	-19.00%-746.28K	-19,310.40%-627.15K	-3.23K
Non-operating interest income	-60.43%48.01K	340.11%121.32K	112.41%27.57K	390.44%12.98K	--2.65K
Non-operating interest expense	-36.40%211.03K	-57.12%331.81K	20.89%773.85K	10,792.07%640.13K	--5.88K
Other net income (expenses)	-43.11%4.95M	80.49%8.71M	131.77%4.83M	889.33%2.08M	-263.79K
Special income (charges)	70.62%-292	59.40%-994	-18.55%-2.45K	---2.07K	----
-Gain on sale of property,plant,equipment	70.62%-292	59.40%-994	-18.55%-2.45K	---2.07K	----
Other non-operating income (expenses)	-43.12%4.96M	80.42%8.71M	131.66%4.83M	890.11%2.08M	---263.79K
Income before tax	17.58%-10.32M	50.72%-12.52M	-75.71%-25.41M	4.33%-14.46M	-15.11M
Income tax	1,045.08%110.81K	-89.57%9.68K	-43.31%92.82K	163.72K	0
Earnings from equity interest net of tax
Net income	16.76%-10.43M	50.86%-12.53M	-74.38%-25.5M	3.24%-14.62M	-15.11M
Net income continuous operations	16.76%-10.43M	50.86%-12.53M	-74.38%-25.5M	3.24%-14.62M	---15.11M
Noncontrolling interests
Net income attributable to the company	16.76%-10.43M	50.86%-12.53M	-74.38%-25.5M	3.24%-14.62M	-15.11M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	16.76%-10.43M	50.86%-12.53M	-74.38%-25.5M	3.24%-14.62M	-15.11M
Diluted earnings per share	55.08%-0.77	69.44%-1.7143	-45.07%-5.6095	47.35%-3.8667	-7.3437
Basic earnings per share	55.08%-0.77	69.44%-1.7143	-45.07%-5.6095	47.35%-3.8667	-7.3437
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Middle East conflict spreads to the stock market! How should investors respond?

On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm